- Diagnostic specificity is not just a documentation issue – it is a direct driver of financial performance
- Gaps in specificity affect 15.6% of encounters, leading to denials, rework, and delayed reimbursement
- A typical provider organization may be losing $1.84M–$2.9M annually due to these gaps
- These gaps are not random – they are shaped by how health technology platforms capture and structure clinical data
Health technology companies have a clear opportunity to improve customer ROI by reducing these inefficiencies and recovering lost revenue.
Platforms that preserve diagnostic specificity can lower cost to collect, accelerate reimbursement, and drive measurable financial gains for provider customers.
IMO Health’s Knowledge Graph enables this by preserving clinical meaning from the point of documentation to the revenue cycle – ensuring diagnostic specificity is captured, translated, and operationalized to improve reimbursement accuracy, reduce denials, and strengthen overall revenue cycle performance.
Diagnostic specificity as an overlooked financial lever
Diagnostic specificity is foundational to effective clinical documentation. Accurate, detailed diagnosis coding is required to support care decisions, ensure compliance, and reflect patient complexity.
But diagnostic specificity is also a direct driver of financial performance.
When clinical detail is missing, underspecified, or lost between documentation and coded data, the effects ripple across the healthcare ecosystem – contributing to claim denials, administrative rework, delayed reimbursement, and unreliable analytics.
These challenges are not just documentation issues – they stem from how clinical data is captured, structured, and operationalized across health technology platforms. These platforms play a critical role in determining whether diagnostic specificity is preserved as clinical information moves through claims processing, risk adjustment, analytics, and automation workflows.
For companies building electronic health record (EHR) systems, AI tools, analytics platforms, and digital health infrastructure, diagnostic specificity represents a powerful yet underleveraged opportunity to improve financial outcomes for the provider organizations they serve.
Where diagnostic specificity breaks down
Clinical data can flow through multiple systems before becoming a claim, informing an analytic insight, or triggering downstream workflows. Yet, at each stage – documentation, coding, data processing, and analytics – clinical nuance can be diluted or lost as health technology platforms translate clinician language into structured data.
Clinicians may document a specific condition in narrative form but select a less specific diagnosis code in the EHR. Coding systems themselves often allow unspecified diagnoses even when more precise options exist. Then, downstream systems must rely on those codes rather than the rich detail of clinical notes.
The result is a gap between what clinicians know about a patient and what downstream systems can reliably interpret.
For example, a provider may document pain in the left knee but select a diagnosis code for “pain in unspecified knee.” That loss of specificity may seem minor, but it can affect reimbursement and risk adjustment calculations or result in denied claims and manual intervention by revenue cycle staff.
These gaps are not rare.
Based on an analysis of 39 million patient encounters across 20 sites, IMO Health has identified that 15.6% of encounters are initially coded with unspecified diagnoses (laterality, anatomical location, or condition specificity) that place the claim at significant risk for rework or denial.
And once diagnostic specificity is lost, the consequences extend far beyond documentation. These gaps introduce downstream friction across coding, billing, and revenue cycle workflows – often resulting in rework, delays, or increased risk of denial.
The examples below illustrate how unspecified diagnoses create these challenges, and how more precise clinical representation supports accurate billing.
| Diagnosis (at risk for rework or denial) | Explanation | More accurate clinical representation | Appropriate billing DX (ICD-10) | SNOMED® concept |
|---|---|---|---|---|
| R10.819 – Abdominal tenderness, unspecified site | Administrative rework due to potential denial resulting from unspecified anatomical site | Suprapubic tenderness (IMO ID 1049648) | R10.8A3 – Suprapubic tenderness | 43478001 – Abdominal tenderness (finding) |
| M54.50 – Low back pain, unspecified | Administrative rework due to potential denial resulting from unspecified anatomical site | Chronic left-sided low back pain with left-sided sciatica (IMO ID 66945686) | M54.52 – Lumbago with sciatica, left side | 278860009 – Chronic low back pain (finding) |
| H91.90 – Unspecified hearing loss, unspecified ear | Administrative rework due to potential denial resulting from unspecified laterality and unspecified condition detail | Noise-induced hearing loss of left ear, unspecified hearing status on contralateral side (83307068) | H83.3X2 – Noise effects on left inner ear | 1089221000119100 – Hearing loss of left ear caused by noise (disorder) |
The financial impact of missed diagnostic specificity
Since health technology platforms shape how clinical documentation, coding, and revenue cycle workflows function, product design directly influences whether that specificity is captured or lost. This introduces inefficiencies across the revenue cycle and administrative workflows.
Even small gaps in specificity scale quickly across large patient volumes. Indeed, a single-digit percentage can translate into thousands of affected encounters and hundreds of thousands of dollars.
While the financial impact of lost clinical detail varies based on a number of organization-specific factors, we’ve compared industry benchmarks with our data set to project its impact on outpatient revenue.
Increased cost to collect, resulting from:
Administrative rework
Claims with underspecified diagnoses often require manual review and correction before submission – impacting approximately 9.4% of encounters and representing $826K–$1.35m in avoidable annual cost for a typical provider organization.
Denials management and resubmission
Some claims still reach payers without sufficient specificity, resulting in avoidable denials – affecting approximately 4.6% of encounters and representing $665K–$997K in additional administrative costs annually.
Cashflow impact, resulting from:
Reduced reimbursement
Underspecified diagnoses, affecting approximately 1.6% of encounters – may not fully reflect patient complexity, leading to $127K–$191K in lost annual reimbursement.
Delayed reimbursement
Rework and denials extend time to payment by an average of 3 – 5 days – impacting approximately 15.6% of encounters and contributing to an estimated $218K – $363K in delayed cash flow.
Taken together, this analysis indicates that a typical provider organization1 (800,000 annual outpatient encounters, $170M in revenue, baseline of 40 AR days) may be losing between $1.15M and $1.67M annually due to gaps in diagnostic specificity.
For health technology companies, these inefficiencies represent a measurable opportunity to improve financial outcomes for provider customers. Platforms that capture and preserve diagnostic specificity can help reduce avoidable costs, accelerate reimbursement, and prevent millions in revenue loss.
In the acute setting, the financial stakes are even higher. Diagnostic specificity directly influences diagnostic-related assignment and reimbursement, making it a critical lever for any platform supporting clinical documentation or revenue cycle workflows within the hospital. While variability across organizations makes precise modeling complex, the potential impact is significantly greater than in outpatient settings.
| Category | Event |
|---|---|
| Increased cost to collect | Administrative rework |
| Denial resolution | |
| Cashflow impact | Unrecoverable denials |
| Increased AR days | |
| Total financial impact | $1.84M - $2.90M |
Model assumptions: Estimates are based on IMO Health analysis of 39M encounters across 20 sites and industry benchmarks. Assumptions include average resolution times (10–20 minutes for rework; 20–30 minutes for denial resolution), weighted labor costs across clinical and revenue cycle roles, estimated reimbursement reductions for unspecified diagnoses, and a 5-day average delay in reimbursement for affected encounters. These assumptions are informed by AHIMA coding productivity and workforce cost benchmarks and HFMA revenue cycle cost-to-collect and staffing benchmarks.*
Bridging the specificity gap with IMO Health’s Knowledge Graph
Closing the diagnostic specificity gap requires more than static coding systems.
Clinical data begins with clinician language – the terms used in documentation, problem lists, and care notes. But translating that language into structured, usable data requires a deep understanding of clinical knowledge and coding.
IMO Health’s Knowledge Graph provides that foundation.
A knowledge graph is a structured representation of real-world entities and the relationships between them. They are designed to give both humans and AI systems a shared understanding of the relationships between data points.
Built on decades of real interactions between patients and providers, IMO Health’s Knowledge Graph represents clinical concepts and their connections. This foundation enables health technology platforms to ground their AI models in accurate, real-time clinical data.
By integrating this invaluable context layer, platforms can:
- Extract and normalize clinician language into precise structured codes
- Identify more specific diagnoses by uncovering laterality, severity, or encounter type
- Maintain continuously updated terminology mappings as clinical language, coding standards, and care practices evolve
This, in turn, improves the accuracy of claims, analytics, and automation workflows.
Rather than forcing clinicians to navigate complex coding systems, IMO Health’s Knowledge Graph enables technology platforms to “speak clinician,” preserving clinical meaning as data moves across systems.
Conclusion
Diagnostic specificity is not just a documentation requirement, it is a direct driver of financial performance.
When specificity is lost, the impact is immediate and detrimental: more denials, more rework, slower reimbursement, and lost revenue.
Health technology platforms have an imperative to address this challenge. By improving how clinical language is translated into structured data, they can reduce friction across the revenue cycle and deliver meaningful financial outcomes for provider organizations.
IMO Health’s Knowledge Graph allows health tech products to preserve clinical meaning from the point of care through downstream revenue cycle functions, bridging costly gaps in specificity and paving the way for measurable, scalable financial gains.
To learn how IMO Health’s Knowledge Graph can help your platform capture diagnostic specificity and improve financial outcomes, contact sales@imohealth.com or visit imohealth.com/imo-health-platform.
1Typical provider organization defined as ~800,000 annual outpatient encounters and ~$170M in net patient revenue, and a baseline of 40 A/R days based on IMO Health analysis and industry benchmarks.
*Sources:
Health Financial Management Association (HFMA). MAP Keys (industry benchmark framework). Accessed via: https://www.hfma.org/operations/revenue-cycle/map-keys/
Health Financial Management Association (HFMA). Strategies for Reducing Denials. Accessed via: https://www.hfma.org/revenue-cycle/denials-management/
American Health Information Management Association (AHIMA). Coding Productivity Benchmarks. Accessed via: https://www.ahima.org/topics/productivity/
American Health Information Management Association (AHIMA). Revenue Cycle and Coding Practice Resources. Accessed via: https://www.ahima.org/topics/revenue-cycle/
American Health Information Management Association (AHIMA). Query Practice Briefs. Accessed via: https://www.ahima.org/practice-briefs/
